LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Adagio Medical Holdings, Inc

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERADGM
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / ADGM COVERAGE

What’s moving Adagio Medical Holdings, Inc now

Current reporting with the operating signal separated from the noise.

01
Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System

Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System

The story matters when it changes Adagio Medical Holdings, Inc’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest ADGM filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-12 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-12 · Period 2025-09-30SEC ↗10-K/AAnnual financial reportFiled 2026-07-13 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-06-16 · Period 2026-06-16SEC ↗8-KMaterial company eventFiled 2026-06-12 · Period 2026-06-12SEC ↗8-KMaterial company eventFiled 2026-05-21 · Period 2026-05-21SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-30 · Period 2026-06-16SEC ↗SCHEDULE 13G/AOfficial SEC filingFiled 2026-07-28SEC ↗
EARNINGS / QUARTERLY TRACKER

Adagio Medical Holdings, Inc, quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.